| Execution period | The survey is open until August 14, 2026. |
|---|
BSE filing, NSE: LTM. Summary written from the filing by ALFA Finder's alert engine.
LTM Ltd: key numbers
- Share price
- ₹4,104.00
- Market cap
- ₹1,21,742 Cr
- Revenue (annual)
- ₹42,308 Cr
- Net profit (annual)
- ₹5,018 Cr
- P/E (TTM)
- 23.3×Sector 23.0×
- Promoter holding
- 69.01%+0.52% QoQ
- FII holding
- 6.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from LTM Ltd
All →LTM Bags ₹950 Cr Order from Large global banking and financial services firm
LTM secured a two-year strategic engagement with a global BFSI firm worth up to USD 100 million (₹950 Cr). Scope covers technology consolidation across banking functions.
- Value
- ₹950.0 Cr
- From
- Large global banking and financial services firm (unnamed)
- Execution
- 2 years with option to extend for 1 additional year
LTM Capacity Expansion
LTM launched its BlueVerse Industrial AI Lab in Chennai on October 23, 2026. The co-innovation hub enables enterprises to scale AI across physical operations and intelligent products.
LTM Investor Presentation: Key Takeaways
LTM reported Q2 FY27 revenue of USD 1.24 billion, up 5.1% YoY in CC. The firm is pivoting to an AI-centric model with AI revenue reaching 13.4% of total sales.
LTM Other Announcement
This filing presents the quarterly shareholding pattern of LTM Ltd as required under SEBI regulations. It contains no material corporate events or transactions.
LTM Product Launch
LTM launches BlueVerse ValueMesh, an AI execution fabric to industrialize AI across Oracle transformations. The product unifies AI-native delivery, intelligent automation, and managed services for enterprise clients.
LTM Management Change
LTM Limited has appointed Anupam Kumar as a Non-Executive Non-Independent Director, effective October 16, 2026.
Other other announcement announcements
All →Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.
Himadri Speciality Chemical Other Announcement
Himadri Speciality Chemical's members approved an alteration of its Memorandum of Association and adoption of a new MOA under the Companies Act, 2013. The approval was by special resolution through postal ballot on October 27, 2026.
Aeroflex Industries Other Announcement
Aeroflex Industries filed its Reg 32 statement for the quarter ended September 30, 2026, on its preferential issue proceeds. It reports no deviation or variation and states the full Rs. 54.99 Crore has been utilised.
Adani Enterprises Other Announcement
Adani Enterprises confirmed no deviation in use of rights issue proceeds for the quarter ended 30 September 2026. The filing is a routine Regulation 32 utilisation statement.